Filana Therapeutics, Inc. (FLNA)
NASDAQ: FLNA · Real-Time Price · USD
0.7260
+0.0060 (0.83%)
At close: Sep 18, 2026, 4:00 PM EDT
0.7259
-0.0001 (-0.01%)
After-hours: Sep 18, 2026, 7:58 PM EDT
Filana Therapeutics Market Cap
Filana Therapeutics has a market cap or net worth of $35.07 million as of September 18, 2026. Its market cap has decreased by -65.10% in one year.
Market Cap
35.07M
Enterprise Value
-47.61M
1-Year Change
-65.10%
Ranking
Category
Stock Price
$0.73
ChartMarket Cap Chart
Since July 14, 2000, Filana Therapeutics's market cap has decreased from $565.10M to $35.07M, a decrease of -93.79%. That is a compound annual growth rate of -10.07%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 18, 2026 | 35.10M | -63.28% |
| Dec 31, 2025 | 95.60M | -15.77% |
| Dec 31, 2024 | 113.50M | -88.04% |
| Dec 29, 2023 | 949.30M | -19.80% |
| Dec 30, 2022 | 1.18B | -32.32% |
| Dec 31, 2021 | 1.75B | 902.69% |
| Dec 31, 2020 | 174.40M | 94.86% |
| Dec 31, 2019 | 89.50M | 513.01% |
| Dec 31, 2018 | 14.60M | -44.70% |
| Dec 29, 2017 | 26.40M | 0.38% |
| Dec 30, 2016 | 26.30M | -67.17% |
| Dec 31, 2015 | 80.10M | -13.78% |
| Dec 31, 2014 | 92.90M | -57.93% |
| Dec 31, 2013 | 220.80M | 80.84% |
| Dec 31, 2012 | 122.10M | -28.01% |
| Dec 30, 2011 | 169.60M | -41.19% |
| Dec 31, 2010 | 288.40M | 27.44% |
| Dec 31, 2009 | 226.30M | -8.97% |
| Dec 31, 2008 | 248.60M | -46.82% |
| Dec 31, 2007 | 467.50M | 18.81% |
| Dec 29, 2006 | 393.50M | 32.67% |
| Dec 30, 2005 | 296.60M | -5.66% |
| Dec 31, 2004 | 314.40M | 28.01% |
| Dec 31, 2003 | 245.60M | 277.85% |
| Dec 31, 2002 | 65.00M | -73.54% |
View and export this data all the way back to 2000. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Immutep | 39.81M |
| Seres Therapeutics | 39.77M |
| Lite Strategy | 38.45M |
| Actinium Pharmaceuticals | 38.36M |
| Celularity | 37.92M |
| CervoMed | 36.74M |
| BriaCell Therapeutics | 36.70M |
| aTyr Pharma | 35.61M |